Dr. Yee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1624 S I St
Tacoma, WA 98405Phone+1 253-383-3366Fax+1 253-383-3376
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1986 - 1989
- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Transitional Year, 1984 - 1985
- David Geffen School of Medicine at UCLAClass of 1984
Certifications & Licensure
- HI State Medical License 1999 - 2020
- WA State Medical License 2000 - 2019
Publications & Presentations
PubMed
- 72 citationsPhase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin (NPI-2358) in Patients with Solid Tumors or LymphomasMonica M. Mita, Matthew A. Spear, Lorrin K. Yee, Alain C. Mita, Elisabeth I. Heath
Clinical Cancer Research. 2010-12-01 - 49 citationsInter- and intraindividual variation in dihydropyrimidine dehydrogenase activity in peripheral blood mononuclear cellsJean L. Grem, Lorrin K. Yee, David Venzon, Chris H. Takimoto, Carmen J. Allegra
Cancer Chemotherapy and Pharmacology. 1997-01-01 - 52 citationsTRAIL receptor agonist conatumumab with modified FOLFOX6 plus bevacizumab for first-line treatment of metastatic colorectal cancer: A randomized phase 1b/2 trial.Charles S. Fuchs, Marwan Fakih, Lee S. Schwartzberg, Allen Lee Cohn, Lorrin Yee
Cancer. 2013-12-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: